Chulani Karunatilake
About Chulani Karunatilake
Title and Current Role
Chulani Karunatilake serves as the Chief Technology Officer. His expertise in technology and leadership in biochemistry and pharmaceutical development have positioned him to lead technological innovation and strategic initiatives in his current role.
Education and Expertise
Chulani Karunatilake earned a Ph.D. in Chemistry/Biochemistry from the University of Illinois. He also holds a B.S. in Chemistry from the University of Colombo in Sri Lanka. His academic background provides a strong foundation in chemical and biochemical principles, which he applies in his professional roles in pharmaceutical development and technology.
Background and Career History
Chulani Karunatilake has a robust background, having served as Senior Vice President of Technical Operations for Maverick Therapeutics before its acquisition by Takeda. He was also Senior Vice President of Biologics CMC and initially Vice President of Pharmaceutical Development and Manufacturing at Nektar Therapeutics. His career includes numerous leadership positions at notable companies such as Amgen, Chiron/Novartis, Genentech, and Eli Lilly.